• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用一种促记忆的GABA-A α5选择性反向激动剂进行慢性治疗可增加小鼠记忆处理过程中即早基因的表达,并纠正唐氏综合征小鼠模型中它们的表达水平。

Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model.

作者信息

Braudeau J, Dauphinot L, Duchon A, Loistron A, Dodd R H, Hérault Y, Delatour B, Potier M C

机构信息

Centre de Recherche de l'Institut du Cerveau et de Moelle Epinière, INSERM UMRS 975, CNRS UMR7225, UPMC, 75013 Paris, France.

出版信息

Adv Pharmacol Sci. 2011;2011:153218. doi: 10.1155/2011/153218. Epub 2011 Oct 19.

DOI:10.1155/2011/153218
PMID:22028705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3199058/
Abstract

Decrease of GABAergic transmission has been proposed to improve memory functions. Indeed, inverse agonists selective for α5 GABA-A-benzodiazepine receptors (α5IA) have promnesiant activity. Interestingly, we have recently shown that α5IA can rescue cognitive deficits in Ts65Dn mice, a Down syndrome mouse model with altered GABAergic transmission. Here, we studied the impact of chronic treatment with α5IA on gene expression in the hippocampus of Ts65Dn and control euploid mice after being trained in the Morris water maze task. In euploid mice, chronic treatment with α5IA increased IEGs expression, particularly of c-Fos and Arc genes. In Ts65Dn mice, deficits of IEGs activation were completely rescued after treatment with α5IA. In addition, normalization of Sod1 overexpression in Ts65Dn mice after α5IA treatment was observed. IEG expression regulation after α5IA treatment following behavioral stimulation could be a contributing factor for both the general promnesiant activity of α5IA and its rescuing effect in Ts65Dn mice alongside signaling cascades that are critical for memory consolidation and cognition.

摘要

有人提出降低GABA能传递可改善记忆功能。事实上,对α5 GABA-A-苯二氮䓬受体具有选择性的反向激动剂(α5IA)具有促记忆活性。有趣的是,我们最近发现α5IA可以挽救Ts65Dn小鼠的认知缺陷,Ts65Dn小鼠是一种GABA能传递改变的唐氏综合征小鼠模型。在此,我们研究了在Morris水迷宫任务中训练后,α5IA慢性治疗对Ts65Dn小鼠和对照正常小鼠海马体基因表达的影响。在正常小鼠中,α5IA慢性治疗增加了即刻早期基因(IEGs)的表达,尤其是c-Fos和Arc基因。在Ts65Dn小鼠中,用α5IA治疗后IEGs激活缺陷完全得到挽救。此外,观察到α5IA治疗后Ts65Dn小鼠中Sod1过表达的正常化。行为刺激后α5IA治疗后的IEG表达调节可能是α5IA的一般促记忆活性及其对Ts65Dn小鼠的挽救作用的一个促成因素,同时还有对记忆巩固和认知至关重要的信号级联反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/2e4a4f2b9629/APS2011-153218.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/db2626299f6b/APS2011-153218.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/8c6562f00667/APS2011-153218.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/f43a3ad69ee5/APS2011-153218.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/5704218319e6/APS2011-153218.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/848f8dbcae18/APS2011-153218.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/248e4eb748b9/APS2011-153218.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/2e4a4f2b9629/APS2011-153218.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/db2626299f6b/APS2011-153218.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/8c6562f00667/APS2011-153218.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/f43a3ad69ee5/APS2011-153218.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/5704218319e6/APS2011-153218.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/848f8dbcae18/APS2011-153218.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/248e4eb748b9/APS2011-153218.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036b/3199058/2e4a4f2b9629/APS2011-153218.007.jpg

相似文献

1
Chronic Treatment with a Promnesiant GABA-A α5-Selective Inverse Agonist Increases Immediate Early Genes Expression during Memory Processing in Mice and Rectifies Their Expression Levels in a Down Syndrome Mouse Model.用一种促记忆的GABA-A α5选择性反向激动剂进行慢性治疗可增加小鼠记忆处理过程中即早基因的表达,并纠正唐氏综合征小鼠模型中它们的表达水平。
Adv Pharmacol Sci. 2011;2011:153218. doi: 10.1155/2011/153218. Epub 2011 Oct 19.
2
Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5-selective GABA inverse agonist.使用α5选择性GABA反向激动剂对唐氏综合征小鼠模型的体内长时程增强(LTP)和认知缺陷进行长期校正。
Br J Pharmacol. 2020 Mar;177(5):1106-1118. doi: 10.1111/bph.14903. Epub 2020 Jan 9.
3
Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice.选择性 GABA-A 受体 α5 亚基反向激动剂特异性靶向治疗可恢复唐氏综合征小鼠的认知功能缺陷。
J Psychopharmacol. 2011 Aug;25(8):1030-42. doi: 10.1177/0269881111405366. Epub 2011 Jun 21.
4
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.一种对含α5亚基的GABAA受体具有选择性的反向激动剂可增强认知能力。
J Pharmacol Exp Ther. 2006 Mar;316(3):1335-45. doi: 10.1124/jpet.105.092320. Epub 2005 Dec 2.
5
An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze.一种对含α5亚基的GABAA受体具有选择性的反向激动剂可改善Morris水迷宫中的编码和记忆提取,但不影响记忆巩固。
Psychopharmacology (Berl). 2006 Nov;188(4):619-28. doi: 10.1007/s00213-006-0361-z. Epub 2006 Apr 22.
6
GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.GABAA 受体亚型选择性调节剂。二、用于认知增强的 α5 选择性反向激动剂。
Curr Top Med Chem. 2011;11(9):1203-14. doi: 10.2174/156802611795371314.
7
Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.GABAA 受体 α5 亚型选择性反向激动剂 alpha5IA 的临床前和临床药理学。
Pharmacol Ther. 2010 Jan;125(1):11-26. doi: 10.1016/j.pharmthera.2009.09.001. Epub 2009 Sep 19.
8
GABA(A) receptor subtype-selective efficacy: TPA023, an alpha2/alpha3 selective non-sedating anxiolytic and alpha5IA, an alpha5 selective cognition enhancer.GABA(A)受体亚型选择性功效:TPA023,一种α2/α3选择性非镇静抗焦虑药;以及α5IA,一种α5选择性认知增强剂。
CNS Neurosci Ther. 2008 Spring;14(1):25-35. doi: 10.1111/j.1527-3458.2007.00034.x.
9
Occupancy of human brain GABA(A) receptors by the novel α5 subtype-selective benzodiazepine site inverse agonist α5IA as measured using [¹¹C]flumazenil PET imaging.使用 [¹¹C]氟马西尼 PET 成像测量新型 α5 亚型选择性苯二氮䓬受体反向激动剂 α5IA 占据人脑 GABA(A)受体的情况。
Neuropharmacology. 2010 Dec;59(7-8):635-9. doi: 10.1016/j.neuropharm.2010.07.024. Epub 2010 Aug 7.
10
Treating enhanced GABAergic inhibition in Down syndrome: use of GABA α5-selective inverse agonists.治疗唐氏综合征中增强的 GABA 能抑制:使用 GABAα5 选择性反向激动剂。
Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:218-27. doi: 10.1016/j.neubiorev.2013.12.008. Epub 2014 Jan 9.

引用本文的文献

1
The role of Down syndrome cell adhesion molecule in Down syndrome.唐氏综合征细胞粘附分子在唐氏综合征中的作用。
Med Rev (2021). 2024 Feb 9;4(1):31-41. doi: 10.1515/mr-2023-0056. eCollection 2024 Feb.
2
DSCAM gene triplication causes excessive GABAergic synapses in the neocortex in Down syndrome mouse models.DSCAM 基因三重复导致唐氏综合征小鼠模型新皮层中 GABA 能突触过度形成。
PLoS Biol. 2023 Apr 20;21(4):e3002078. doi: 10.1371/journal.pbio.3002078. eCollection 2023 Apr.
3
One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosage.

本文引用的文献

1
Specific targeting of the GABA-A receptor α5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice.选择性 GABA-A 受体 α5 亚基反向激动剂特异性靶向治疗可恢复唐氏综合征小鼠的认知功能缺陷。
J Psychopharmacol. 2011 Aug;25(8):1030-42. doi: 10.1177/0269881111405366. Epub 2011 Jun 21.
2
Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans.成人海马体干细胞的低增殖和分化能力与人类的记忆功能障碍有关。
Brain. 2010 Nov;133(11):3359-72. doi: 10.1093/brain/awq215. Epub 2010 Aug 18.
3
Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.
唐氏综合征患者血浆中的一碳代谢途径代谢物发生改变:与染色体剂量的关系。
Front Med (Lausanne). 2022 Dec 1;9:1006891. doi: 10.3389/fmed.2022.1006891. eCollection 2022.
4
Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome.唐氏综合征 Ts65Dn 小鼠模型中的胆碱能衰老。
Neurochem Res. 2022 Oct;47(10):3076-3092. doi: 10.1007/s11064-022-03659-0. Epub 2022 Jun 29.
5
from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome.从基因功能在发育和生理到唐氏综合征整个生命周期的剂量校正。
Genes (Basel). 2021 Nov 20;12(11):1833. doi: 10.3390/genes12111833.
6
Multi-influential genetic interactions alter behaviour and cognition through six main biological cascades in Down syndrome mouse models.多因素遗传相互作用通过唐氏综合征小鼠模型中的六个主要生物学级联改变行为和认知。
Hum Mol Genet. 2021 May 28;30(9):771-788. doi: 10.1093/hmg/ddab012.
7
Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability.前额叶-海马功能连接编码识别记忆,并且在智力障碍中受损。
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11788-11798. doi: 10.1073/pnas.1921314117. Epub 2020 May 11.
8
Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an α5-selective GABA inverse agonist.使用α5选择性GABA反向激动剂对唐氏综合征小鼠模型的体内长时程增强(LTP)和认知缺陷进行长期校正。
Br J Pharmacol. 2020 Mar;177(5):1106-1118. doi: 10.1111/bph.14903. Epub 2020 Jan 9.
9
Neurobiology and Therapeutic Potential of α5-GABA Type A Receptors.α5-γ-氨基丁酸A型受体的神经生物学及治疗潜力
Front Mol Neurosci. 2019 Jul 24;12:179. doi: 10.3389/fnmol.2019.00179. eCollection 2019.
10
Combination of Genetics and Nanotechnology for Down Syndrome Modification: A Potential Hypothesis and Review of the Literature.遗传学与纳米技术结合用于唐氏综合征修正:一种潜在假设及文献综述
Iran J Public Health. 2019 Mar;48(3):371-378.
GABAA 受体 α5 亚型选择性反向激动剂 alpha5IA 的临床前和临床药理学。
Pharmacol Ther. 2010 Jan;125(1):11-26. doi: 10.1016/j.pharmthera.2009.09.001. Epub 2009 Sep 19.
4
Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1).Ts65Dn小鼠模型用于唐氏综合征的行为验证,该模型的遗传背景不含视网膜变性突变Pde6b(rd1) 。
Behav Brain Res. 2010 Jan 5;206(1):52-62. doi: 10.1016/j.bbr.2009.08.034. Epub 2009 Aug 29.
5
The complexity of the GABAA receptor shapes unique pharmacological profiles.GABAA受体的复杂性塑造了独特的药理学特征。
Drug Discov Today. 2009 Sep;14(17-18):866-75. doi: 10.1016/j.drudis.2009.06.009. Epub 2009 Jul 2.
6
Down syndrome--recent progress and future prospects.唐氏综合征——近期进展与未来展望。
Hum Mol Genet. 2009 Apr 15;18(R1):R75-83. doi: 10.1093/hmg/ddp010.
7
RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.RO4938581,一种作用于含GABAAα5亚基受体的新型认知增强剂。
Psychopharmacology (Berl). 2009 Jan;202(1-3):207-23. doi: 10.1007/s00213-008-1357-7. Epub 2008 Oct 21.
8
"Sighted C3H" mice--a tool for analysing the influence of vision on mouse behaviour?“视力正常的C3H”小鼠——一种分析视觉对小鼠行为影响的工具?
Front Biosci. 2008 May 1;13:5810-23. doi: 10.2741/3118.
9
Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.长期给予戊四氮而非多奈哌齐治疗可挽救 Ts65Dn 小鼠(一种唐氏综合征模型)的空间认知能力。
Neurosci Lett. 2008 Mar 5;433(1):22-7. doi: 10.1016/j.neulet.2007.12.039. Epub 2008 Jan 15.
10
Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects.β-咔啉FG-7142的药理学研究,它是GABAA受体苯二氮䓬变构位点的部分反向激动剂:神经化学、神经生理学及行为学效应
CNS Drug Rev. 2007 Winter;13(4):475-501. doi: 10.1111/j.1527-3458.2007.00025.x.